Approval · Notice of Compliance 992 · 2000
WELLBUTRIN SR: Notice of Compliance 992
Issued June 30, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 992
- Date
- June 30, 2000
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate manufacturing site
- Therapeutic class
- Antidepressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| WELLBUTRIN SR | Not yet assigned | — |
Medicinal ingredients
- BUPROPION HYDROCHLORIDE 150 MG per TAB